Sandbox/AIRSG

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Alejandro Lemor, M.D. [2]

Aortic Regurgitation Resident Survival Guide Microchapters
Overview
Causes
FIRE
Diagnosis Acute Chronic
Treatment Acute Chronic
Do's
Don'ts

Overview

Aortic regurgitation (AR) refers to the retrograde or backward flow of blood from the aorta into the left ventricle during diastole. The presentation depends on the response and adaptability of the left ventricle to the increased diastolic volume, in chronic AR the left ventricle has adapted by dilatation of its walls. However, in acute AR, a rapid increase in the diastolic volume is not tolerated by a normal size ventricle and this could lead to cardiogenic shock. The most common causes of acute aortic regurgitation are aortic dissection and infective endocarditis and the preferred treatment in both cases surgical intervention. The most common cause of chronic AR is bicuspid aortic valve and the treatment will depend on the stage of the disease. Acute AR is a life-threatening condition and must be recognized and treated promptly.

Causes

Life Threatening Causes

Life-threatening causes include conditions which may result in death or permanent disability within 24 hours if left untreated.

• Aortic dissection
• Infective endocarditis

Common Causes

• Bicuspid aortic valve
• Senile or degenerative calcific aortic valve disease
• Hypertension
• Idiopathic dilatation of the aorta
• Myxomatous degeneration
• Rheumatic fever

Click here for the complete list of causes.

FIRE: Focused Initial Rapid Evaluation

A Focused Initial Rapid Evaluation (FIRE) should be performed to identify patients in need of immediate intervention. The algorithm below is based on the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease.

Boxes in salmon color signify that an urgent management is needed.

Identify cardinal findings that increase the pretest probability of acute aortic regurgitation ❑ ❑ ❑

Does the patient have any of the following findings that require urgent management? ❑ Tachycardia ❑ Hypotension ❑ Loss of consciousness ❑ Tachypnea

Diagnosis

A complete diagnostic approach should be carried out after a focused initial rapid evaluation is conducted and following initiation of any urgent intervention.

Abbreviations: BP: blood pressure; CXR: chest X-ray; ECG: electrocardiogram; LV: left ventricle; MI: myocardial infarction; TTE: transthoracic echocardiography; TEE: transesophageal echocardiography; TAVR: transcatheter aortic valve replacement

Acute Aortic Regurgitation

Characterize the symptoms: ❑ Sudden and severe dyspnea ❑ Palpitations Symptoms suggestive of aortic dissection ❑ Chest pain ❑ Sudden onset ❑ Intense ❑ Tearing and sharp ❑ Worsened by deep breathing or cough ❑ Relieved by sitting upright ❑ Syncope Symptoms suggestive of infective endocarditis ❑ Fever ❑ Sweats ❑ Fatigue ❑ Pleuritic chest pain ❑ Back pain ❑ Weakness ❑ Myalgias

Inquire about past medical history: ❑ Cardiac disease: ❑ Hypertension ❑ Bicuspid aortic valve ❑ Rheumatic fever ❑ Marfan syndrome ❑ Connective tissue disorder ❑ Prosthetic valves ❑ Intravenous drug use ❑ Substances used in the mixture ❑ Sharing the equipment ❑ The process of cleaning the equipment ❑ Previous infective endocarditis

Examine the patient: Vitals ❑ Temperature ❑ Fever (suggestive of infective endocarditis) ❑ Heart rate: ❑ Tachycardia ❑ Blood pressure: ❑ Systolic BP differential > 20 mmHg ❑ Hypertension (suggestive of aortic dissection) Cardiovascular examination ❑ Pulses ❑ Weak ❑ Cardiac auscultation ❑ Murmur ❑ Low pitched early diastolic murmur (may be absent) ❑ Best heard at the right 2nd intercostal space in aortic dissection ❑ Heart sounds ❑ Decreased or absent S1 ❑ Increased P2 (suggestive of pulmonary hypertension) ❑ S3 may be present Respiratory examination ❑ Rales (suggestive of pulmonary congestion)

Order labs and tests: ❑ TTE (most important evaluation test) (Class I; Level of Evidence: B) In high suspicion of aortic dissection, perform a TEE ❑ Chest X-ray ❑ Increase cardiac silhouette (suggestive of aortic dissection) ❑ Widened mediastinum (suggestive of aortic root dilation) ❑ Pulmonary congestion (suggestive of pulmonary hypertension) ❑ ECG ❑ Nonspecific changes of ST and T wave (due to LV enlargement) ❑ Right coronary artery ischemic changes (suggestive of aortic dissection) ❑ ST elevation in II, III, aVF (Inferior MI) ❑ ST elevation in V3R and V4R (Right ventricle MI) ❑ ST depression in V1-V3 (Posterior MI) ❑ Blood culture (if suspected infective endocarditis) ❑ Cardiac enzymes (Troponin, CK-MB)

Determine the etiology of the aortic regurgitation

Aortic dissection Diagnostic clues: ❑ Chest pain of the following characteristics: ❑ Sudden onset ❑ Intense ❑ Tearing and sharp ❑ Worsened by deep breathing or cough ❑ Relieved by sitting upright ❑ Syncope ❑ Low pitched early diastolic murmur ❑ Best heard at the right 2nd intercostal space ❑ Previous history of: ❑ Marfan syndrome ❑ Connective tissue disorder

Infective endocarditis Diagnostic clues: ❑ Persistent fever ❑ New valvular regurgitation murmur ❑ Positive blood culture ❑ Vegetations found on TTE ❑ High risk factors: ❑ Pre-existing cardiac abnormality ❑ Prosthetic valve ❑ Recent surgical or medical procedures ❑ Intravenous drug use ❑ Recent bacterial infection ❑ History of previous endocarditis ❑ Evaluate the modified Duke criteria (click here to see the modified Duke criteria )

Other causes ❑ Complication of: ❑ TAVR ❑ Percutaneous aortic balloon dilation ❑ Prosthetic valve dysfunction ❑ Blunt chest trauma

Click here for aortic dissection resident survival guide

Click here for infective endocarditis resident survival guide

Treat the underlying cause of acute aortic regurgitation

Chronic Aortic Regurgitation

Characterize the symptoms: ❑ Dyspnea on exertion ❑ Orthopnea ❑ Paroxysmal nocturnal dyspnea ❑ Palpitations ❑ Chest pain

Inquire about past medical history: ❑ Cardiac disease: ❑ Hypertension ❑ Bicuspid aortic valve ❑ Rheumatic fever ❑ Pulmonary disease

Examine the patient: Vitals ❑ Heart rate: ❑ Tachycardia (suggestive of reduced stroke volume) ❑ Blood pressure: ❑ Wide pulse pressure (≥ 60 mmHg) Cardiovascular examination ❑ Pulses ❑ Corrigan's pulse: a rapid upstroke and collapse of the carotid artery pulse ❑ Cardiac auscultation ❑ Murmur ❑ Early diastolic decrescendo murmur ❑ Best heard at the upper left sternal border ❑ Murmur increases with sitting forward, expiration and handgrip ❑ Austin Flint murmur: a soft mid-diastolic rumble, best heard at the cardiac apex ❑ Heart sounds ❑ S3 may be present (suggestive of left ventricular dysfunction) ❑ Search for other signs suggestive of aortic regurgitation ❑ Traube's sign: systolic and diastolic murmurs described as 'pistol shots' heard over the femoral artery when it is gradually compressed ❑ Müller's sign: systolic pulsations of uvula ❑ de Musset's sign: head bobbing with each heart beat ❑ Hill's sign: ≥ 20 mmHg difference in popliteal and brachial systolic cuff pressures (suggestive of chronic severe AR) ❑ Quincke's sign: pulsation of the capillary bed in the nail Respiratory examination ❑ Rales (seen when congestive heart failure has developed)

Order imaging studies: ❑ TTE (most important evaluation test) (Class I; Level of Evidence: B) Assess the following: ❑ Valve morphology ❑ Pressure gradient ❑ Aortic valve area ❑ Ejection fraction ❑ LV wall thickness and motility ❑ Chest X-ray ❑ Increase cardiac silhouette (suggestive of aortic dissection) ❑ Widened mediastinum (suggestive of aortic root dilation) ❑ Pulmonary congestion (suggestive of HF) ❑ ECG ❑ Nonspecific changes of ST and T wave (due to LV enlargement)

Classify aortic regurgitation based on the following findings on TTE: ❑ Vena contracta ❑ Jet/LVOT ❑ Regurgitant volume ❑ Regurgitant fraction ❑ Effective regurgitant orifice

Risk of AI (Stage A) ❑ No regurgitation

Mild (Stage B) ❑ Vena contracta <0.3 cm ❑ Jet/LVOT <25% ❑ Regurgitant volume <30 mL/beat ❑ Regurgitant fraction <30% ❑ Effective regurgitant orifice <0.10 cm²

Moderate (Stage B) ❑ Vena contracta 0.3-0.6 cm ❑ Jet/LVOT 25-64% ❑ Regurgitant volume 30-59 mL/beat ❑ Regurgitant fraction 30-49% ❑ Effective regurgitant orifice 0.10-0.29 cm²

Severe ❑ Vena contracta >0.6 cm ❑ Jet/LVOT ≥ 65% ❑ Regurgitant volume ≥60 mL/beat ❑ Regurgitant fraction ≥50% ❑ Effective regurgitant orifice ≥ 0.30 cm² ❑ Holodiastolic flow reversal in the proximal abdominal aorta

Asymptomatic Stage C1 ❑ Normal LVEF ❑ Mild to moderate dilatation Stage C2 ❑ LV systolic dysfunction ❑ Decreased LVEF or severe LV dilatation

Symptomatic (Stage D) ❑ Normal or decreased LV systolic function ❑ Moderate to severe LV dilatation

Treatment

Acute Aortic Regurgitation

Shown below is an algorithm for the treatment of acute aortic regurgitation according to the 2014 AHA/ACC Guidelines for the Management of Valvular Heart Disease and the 2010 ACCF/AHA Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease

Determine the etiology and the grade of regurgitation

Infective endocarditis

type A aortic dissection

Mild or moderate regurgitation (Stage B)

Severe regurgitation (Stage C or D)

Mild or moderate regurgitation (Stage B)

Severe regurgitation (Stage C or D)

Early mitral valve closure† is present?

Replacement of supra-coronary ascending aorta

Aortic root replacement, OR Valve-sparing aortic root replacement

No

Yes

❑ Antibiotic treatment Click here for a complete list of pathogen specific antibiotics regimens ❑ For severe regurgitation perform serial TEEs

Grade I Mitral valve closure before QRS but after P wave

Grade II Mitral valve closure before P wave

Schedule for AVR if: ❑ Fungal infection, or ❑ Large vegetation, or ❑ Resistant bacterial infection

❑ ICU care ❑ Perform surgery if: ❑ ❑

If presence of mitral regurgitation: ❑ Perform surgery immediately (< 4 hours) If absence of mitral regurgitation: ❑ Perform surgery in less than 24 hours

† Early mitral valve closure refers to the closure of the mitral valve before the QRS due to an increased diastolic left ventricle pressure. Grade I occurs when it happens before QRS but after the P wave. Grade II is the mitral valve closure before the P wave.

Chronic Aortic Regurgitation

Shown below is an algorithm summarizing the treatment approach to chronic aortic regurgitation according to the 2014 AHA/ACC Guidelines on the Management of Valvular Heart Disease.

Interpret results from TTE

No regurgitation (Stage A)

Progressive regurgitation (Stage B) Mild ❑ Vena contracta <0.3 cm ❑ Jet/LVOT <25% ❑ Regurgitant volume <30 mL/beat ❑ Regurgitant fraction <30% ❑ Effective regurgitant orifice <0.10 cm² Moderate ❑ Vena contracta 0.3-0.6 cm ❑ Jet/LVOT 25-64% ❑ Regurgitant volume 30-59 mL/beat ❑ Regurgitant fraction 30-49% ❑ Effective regurgitant orifice 0.10-0.29 cm²

Severe regurgitation ❑ Vena contracta >0.6 cm ❑ Jet/LVOT ≥ 65% ❑ Regurgitant volume ≥60 mL/beat ❑ Regurgitant fraction ≥50% ❑ Effective regurgitant orifice ≥ 0.30 cm² ❑ Holodiastolic flow reversal in the proximal abdominal aorta

Asymptomatic patients ❑ Normal valve ❑ Bicuspid valve ❑ Sclerotic valve

Asymptomatic patients ❑ Control hypertension preferably with ❑ Dihydropyridine calcium channel blockers, or ❑ ACE inhibitors/ARBs (Class I; Level of Evidence: B)

Asymptomatic (Stage C)

Symptomatic (Stage D)

❑ Perform a periodic echocardiogram (Class I; Level of Evidence:B) ❑ Every 3 -5 years for mild regurgitation ❑ Every 1 - 2 years for moderate regurgitation

Stage C1 ❑ Normal LVEF ❑ Mild to moderate dilatation

Stage C2 ❑ LV systolic dysfunction, and ❑ Decreased LVEF, or ❑ Severe LV dilatation

Perform a periodic echocardiogram every 6 - 12 months (Class I; Level of Evidence: B)

❑ Schedule for AVR (Class I; Level of Evidence: B) ❑ Administer ACE inhibitors/ARBs or beta blockers if patient has contraindications for surgery

If patient undergoes another cardiac surgery: ❑ Schedule for AVR (Class IIa; Level of Evidence: C)

Choice of Intervention

Shown below is an algorithm summarizing the choice of the intervention to aortic stenosis based on the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease

Patient scheduled for AVR

High risk

Low to moderate risk

❑ A multidisciplinary group should decide intervention (Surgical AVR or TAVR) (Class I; Level of Evidence: C) ❑ Schedule for TAVR (Class IIa; Level of Evidence: B)

❑ Schedule for surgical AVR (Class I; Level of Evidence: A)

Do's

❑

Don'ts

❑ Do not use beta blockers in AI of causes other than AD as it will block the compensation tachycardia. ❑ Do not use intra-aortic baloon counterpulsation in severe acute AI as it will increase the aortic diastolic pressure and the regurgitant volume.

References

Template:WikiDoc Sources